Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

TinotendaHlatywayo/MDR-TB-Risk-Factors-in-Africa

Domaine:

healthcare

Type de record:

project
Créateur:
Tin
Hôte:
WHO-MDR-TB-Africa-Risk-Factors analyzes WHO TB data to identify MDR-TB risk factors in Africa using ML (Random Forest, etc.). EDA and visualizations highlight HIV co-infection as key. With 86.6% accuracy, it informs interventions, focusing on high-burden Southern Africa. # Identification of Risk Factors for MDR-TB in Africa The **WHO-MDR-TB-Africa-Risk-Factors** repository contains a comprehensive analysis of WHO tuberculosis data to identify key risk factors for multidrug-resistant tuberculosis (MDR-TB) in African populations. Using machine learning techniques, including Random Forest, Logistic Regression, SVM, KNN, and Gradient Boosting, the project preprocesses and analyzes data from African countries, focusing on variables such as HIV co-infection, retreatment cases, and demographics. Exploratory data analysis (EDA) and visualizations, including regional prevalence maps and correlation plots, reveal insights into MDR-TB burden, with Southern Africa, particularly South Africa, showing the highest prevalence. The Random Forest model, achieving an average cross-validation accuracy of 86.6%, identifies HIV-positive TB cases as the most significant risk factor. The repository aims to inform targeted interventions and public health policies to mitigate drug-resistant TB in Africa. # Installation ## Clone the repository: github.com # Data Source ## WHO TB data from Kaggle. Link to dataset: kaggle.com # Key Findings Random Forest model (86.6% accuracy) identifies HIV-positive TB cases as the top risk factor for MDR-TB. Southern Africa, especially South Africa, has the highest MDR-TB burden. Visualizations include regional prevalence, HIV-TB correlations, and choropleth maps. # Contact For questions, contact [hlatwayne@gmail.com] or open an issue on GitHub.

Visit

github.com

Similaires

Risk Factors of Gout in MDR-TB Patients in Eritrea: A Case-Control StudyPrevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern EthiopiaAfrica — WHO GHO: Confirmed cases of RR-/MDR-TBMULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB): AN EMERGING PROBLEM IN WEST AFRICAUnivariate and multivariate logistic regression result of risk factors for development of MDR-TB, Addis Ababa, January, 2017 (n = 226).Clinical characteristics of MDR/RR-TB patients at baseline and/or during MDR-TB initiated on treatment in Zimbabwe, 2010–2015.

Risk Factors of Gout in MDR-TB Patients in Eritrea: A Case-Control Study

Though the incidence of gout in general population is less than 5% (globally), a study conducted in

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia

Background . Tuberculosis (TB) is one of the major public health problems. There are alarming report

Africa — WHO GHO: Confirmed cases of RR-/MDR-TB

Indicator code: TB_rr_mdr HuggingFace slug: electricsheepafrica/africa-who-confirmed-cases-of-rr-mdr

MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB): AN EMERGING PROBLEM IN WEST AFRICA

Background Multidrug-resistant tuberculosis (MDR-TB) remains a clear threat to T

Univariate and multivariate logistic regression result of risk factors for development of MDR-TB, Addis Ababa, January, 2017 (n = 226).

Univariate and multivariate logistic regression result of risk factors for development of MDR-TB,

Clinical characteristics of MDR/RR-TB patients at baseline and/or during MDR-TB initiated on treatment in Zimbabwe, 2010–2015.

Clinical characteristics of MDR/RR-TB patients at baseline and/or during MDR-TB initiated on trea